Campbell & Co Investment Adviser’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.47M Buy
7,041
+4,091
+139% +$4.15M 0.37% 42
2025
Q4
$3.17M Sell
2,950
-482
-14% -$461K 0.15% 198
2025
Q3
$2.62M Buy
+3,432
New +$2.55M 0.2% 120
2025
Q2
Sell
-1,356
Closed -$1.12M 1312
2025
Q1
$1.12M Buy
+1,356
New +$1.13M 0.09% 385
2024
Q4
Sell
-758
Closed -$672K 1224
2024
Q3
$672K Sell
758
-9,055
-92% -$8.14M 0.05% 595
2024
Q2
$8.88M Buy
9,813
+8,847
+916% +$7.08M 0.76% 5
2024
Q1
$752K Buy
+966
New +$687K 0.06% 515
2023
Q4
Sell
-435
Closed -$234K 1226
2023
Q3
$234K Buy
+435
New +$224K 0.03% 805
2022
Q3
Sell
-1,029
Closed -$334K 823
2022
Q2
$334K Sell
1,029
-6,743
-87% -$2.02M 0.09% 415
2022
Q1
$2.23M Buy
+7,772
New +$2M 0.6% 6
2021
Q4
Sell
-7,010
Closed -$1.62M 722
2021
Q3
$1.62M Buy
+7,010
New +$1.73M 0.53% 20
2021
Q2
Sell
-2,060
Closed -$385K 630
2021
Q1
$385K Buy
+2,060
New +$403K 0.24% 153
2018
Q2
Sell
-3,787
Closed -$293K 461
2018
Q1
$293K Sell
3,787
-6,300
-62% -$507K 0.25% 173
2017
Q4
$852K Buy
+10,087
New +$858K 0.63% 14
2013
Q3
Sell
-189,241
Closed -$9.3M 314
2013
Q2
$9.3M Buy
+189,241
New +$10.3M 1.79% 4

Other funds holding LLY

Campbell & Co Investment Adviser's LLY Position: Q1 2026 in Review

Campbell & Co Investment Adviser increased its Eli Lilly (LLY) stake by 139% in Q1 2026, buying an estimated $4.15M and bringing the position to 7,041 shares worth $6.47M. The position accounts for 0.37% of the portfolio, ranked #42.

Campbell & Co Investment Adviser first reported a position in LLY in Q2 2013 and has held it in 15 quarters since. The position peaked at $9.3M in Q2 2013. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Campbell & Co Investment Adviser held 7,041 shares of Eli Lilly worth $6.47M as of Q1 2026.
  • Campbell & Co Investment Adviser bought 4,091 Eli Lilly shares in Q1 2026, an estimated $4.15M.
  • Eli Lilly made up 0.37% of Campbell & Co Investment Adviser's portfolio in Q1 2026, its #42 holding.
  • Campbell & Co Investment Adviser first reported a position in Eli Lilly in Q2 2013 and has held it in 15 quarters since.
  • Campbell & Co Investment Adviser's Eli Lilly position peaked at $9.3M in Q2 2013.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.